Skip to content
healthcare.dev

Dexlansoprazole

NDC 62332-823, Dexlansoprazole, capsule, delayed release, from Alembic Pharmaceuticals Inc..

Product NDC
62332-823
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219115
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-823 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXLANSOPRAZOLE30 mg/1

Pharmacologic classes

Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
62332-823-306233208233030 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-823-30)
62332-823-906233208239090 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-823-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f9607c88-03b7-46c6-8b88-84f01dcf2221
  • NADAC price for package 62332082330

    GET /v1/drugs/nadac/62332082330

Use it

Look up 62332-823 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-823 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-823. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.